Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02935283 · ClinicalTrials.gov registry record

Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

A clinical trial of Urea Cycle Disorders, sponsored by Children's National Research Institute.

Recruiting
Registry status
56
Enrollment target
1
Study location

NCT02935283: Recruiting study of Urea Cycle Disorders, sponsored by Children's National Research Institute.

NCT02935283 is a study of Urea Cycle Disorders that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 56 participants, below the 383-participant average among 4 other Urea Cycle Disorders trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02935283, a study of Urea Cycle Disorders, is actively recruiting participants, sponsored by Children's National Research Institute.

RECRUITING
Registry status
56 participants
Enrollment target
1
Study location

Study Summary

In proximal urea cycle disorders (UCD), particularly ornithine transcarbamylase deficiency (OTCD), hyperammonemia (HA) causes increased brain glutamine (Gln) which perturbation is thought to be at the core of the neurological injury. In contrast, in distal UCD such as citrullinemia (argininosuccinate synthetase deficiency; (ASSD) and argininosuccinic aciduria (argininosuccinate lyase deficiency); (ASLD) cognitive impairment and neuropsychiatric disease are common even in the absence of acute HA. As a consequence, both citrulline and argininosuccinate (ASA) or their metabolic products have been implicated as neurotoxic. In this project the investigators will use state-of- the-art neuroimaging and neuropsychological methods to investigate whether patients with OTCD have chronically elevated brain Gln and reduced myo-inositol (mI) levels that correlate with regional brain structural abnormalities and neurocognitive dysfunction. The researchers will further investigate whether during an acute episode of HA elevated brain Gln and decreased mI levels correlate with the magnitude of cytotoxic edema and whether a Gln/mI ratio threshold can be identified at which the cytotoxic edema is followed by cell loss. Finally, the researchers will investigate whether regions of brain damage in ASSD and/or ASLD are distinct from those in OTCD and compare brain Gln levels in ASSD and ASLD in the absence of HA to those in OTCD. The investigators will also seek to determine if brain citrulline and ASA can be identified in the brains of patients with distal UCD and whether they correlate with brain abnormalities seen in MRI and neuropsychological testing. This project will elucidate the chronology of brain pathology both in acute hyperammonemia and chronic UCD and whether, proximal and distal UCD differ in their pathophysiology of brain damage.

Conditions Studied

Interventions

  • PROCEDURE MRI
  • BEHAVIORAL Behavioral

Study Locations (1)

District of Columbia

  • Children's Research Institute - Washington D.C.

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2016-08
Est. Completion 2025-12

What NCT02935283 shows while recruiting

NCT02935283 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 383-participant average among 4 other Urea Cycle Disorders trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Urea Cycle Disorders appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.

NCT02935283 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT02935283 about?

NCT02935283 is a clinical study titled "Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders". In proximal urea cycle disorders (UCD), particularly ornithine transcarbamylase deficiency (OTCD), hyperammonemia (HA) causes increased brain glutamine (Gln) which perturbation is thought to be at the core of the neurological injury. In contrast, in distal UCD such as citrullinemia (argininosuccinat...

What is the current status of trial NCT02935283?

This trial is currently recruiting. The enrollment target is 56 participants. The study started on 2016-08. Estimated completion is 2025-12.

What conditions does trial NCT02935283 study?

This clinical trial studies the following conditions: Urea Cycle Disorders.

What interventions are being tested in trial NCT02935283?

The interventions under investigation include: MRI (PROCEDURE), Behavioral (BEHAVIORAL).

Who is sponsoring clinical trial NCT02935283?

This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02935283 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urea Cycle Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

  • NCT03520647 · 56 participants · Phase 2

    Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02935283, the US trial registry maintained by the National Library of Medicine. NCT02935283 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.